• About
  • 37th Annual Meeting
  • Join SPS
  • News
  • Resources
  • Contact
  • Member Login
Speakers Bureau Search for Provider

President’s Message–Looking Ahead to 2022

President's Notes
Jan 13, 2022
0 Comments

Harry J. Gould, III MD, PhD

Once again, it is time to begin a brand new year.  Since I stepped into the role of president of the Southern Pain Society, we as a society have experienced moments of promise with the release and early encouraging responses to vaccines to thwart the COVID-19 pandemic. These advances fostered the hope of resuming in person meetings, but the resurgence of the pandemic due to the delta variant dictated

Read More

President’s Message: Running Headlong into what You Thought Was Behind You

Clinical
Oct 15, 2021
0 Comments

With the FDA’s blessing in mid-December on the administration of vaccines for COVID-19 and subsequent indications of downward trends in the rate of infections, hospitalizations and deaths associated with the virus came a feeling that the worst of the pandemic was past and we were on a return path to recover normalcy…

Read More

Personality Disorder Patients in a Pain Clinic: Recognition and Management

Clinical
Oct 15, 2021
0 Comments

Approximately 9.6% of Americans have a personality disorder.1,2  These are common conditions, and all medical professionals encounter patients with such disorders in their practice. Early identification of this group of patients is ideal.  In the following we discuss how patients with these psychiatric conditions may present to an outpatient pain clinic…

Read More

President’s Message: Progress in Mitigating the Negative Effects of the “Opioid Crisis”

Policy
Jul 11, 2021
0 Comments

Harry J. Gould, III, MD, PhD On June 26, 2021, Johnson & Johnson confirmed that in 2020, as part of a $230M settlement with the State of New York, they discontinued promotion and distribution of opioid products in the State of New York. The settlement was made in response to efforts to mitigate the unprecedented […]

Read More

Long Haul COVID-19

Clinical
Jul 11, 2021
0 Comments

Olivia Lee and Lawrence Robbins, MD Introduction Over 325 million doses of COVID-19 vaccines have been distributed in the United States, and much of the country is looking forward to a return to normalcy. For many, the widespread access to vaccines signaled the pandemic’s defeat, but for millions of COVID-19 survivors, the sequelae following acute […]

Read More

ANA2021 Registration Is Now Open!

News
Jul 11, 2021
0 Comments

ANA2021’s Virtual Annual Meeting is set for October 17-19 with an Opening Symposium on October 16 and registration is now open! All full registrations include access to the ANA2021 Meeting Recordings package, ensuring you won’t miss out on the latest neurological research even if your schedule should change. Registration also includes complimentary access to the SIG Series […]

Read More

President’s Message: Thoughts on Addressing Disparity in the Midst of the “Opioid Crisis”

Clinical
Apr 8, 2021
0 Comments

Harry J. Gould, III, MD, PhD Pain occurs in both acute and chronic forms. In its acute form, pain is a modality that is essential for survival and is the signal that most frequently brings people to the attention of the healthcare professional.  Many cases of simple acute pain are readily treated without difficulty by […]

Read More

Adverse Effects and Clinical Trials: The System is Broken

Clinical
Apr 8, 2021
0 Comments

The CGRP Monoclonal Antibodies for Migraine Are a Prime Example Lawrence Robbins, M.D. This letter is in response to an excellent July, 2020 article “Migraine and CGRP Monoclonal Antibodies: A Review of Cardiovascular Side Effects and Safety Profile” (Boldig and Butala) in the International Journal of Neurology and Neurotherapy. (1) There are a plethora of […]

Read More

Back to the Basics: Managing Pain Months After COVID-19

News
Jan 9, 2021
0 Comments

A year ago, the United States was in the midst of understanding and dealing with the complexities of the “Opioid Epidemic”, what until then had been considered the greatest healthcare crisis in U.S. history. Although improvements in some aspects of the crisis were starting to be realized as a result of the development of best evidence-based practice guidelines and the implementation […]

Read More

Case Sample: Bipolar, Chronic Migraine, Epilepsy, and IBS-D

News
Jan 9, 2021
0 Comments

Lawrence Robbins, MD Individuals suffering from chronic pain often have psychiatric comorbidities. For instance, among those with chronic migraine approximately 9% fit into the bipolar spectrum. (1) This article discusses a representative case of a patient with chronic migraine and bipolar disorder as well as epilepsy and irritable bowel syndrome. Caitlin is a 28-year-old female […]

Read More

Page 2 of 9

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

The Southern Pain Society was incorporated in 1989 and covers the 18 southern states and Puerto Rico. Our mission is to serve people with pain by advancing research and treatment and to increase the knowledge and skill of the regional professional community.

All Rights Reserved. Southern Pain Society. Asheville Web Design by Evolv LLC

Southern Pain Society
(828) 575-9275
FAX (866) 368-2700
Southern Pain Society
P.O. Box 2764
Asheville, North Carolina 28802
Contact Us